Literature DB >> 29345160

Inherited forms of bladder cancer: a review of Lynch syndrome and other inherited conditions.

Aaron Phelan1, Antonio Lopez-Beltran2, Rodolfo Montironi3, Shaobo Zhang1, Maria R Raspollini4, Monica Cheng1, Hristos Z Kaimakliotis5, Michael O Koch5, Liang Cheng1,5.   

Abstract

Environmental factors that play a role in the urothelial carcinogenesis have been well characterized. Current research is continuously exploring potential heritable forms of bladder cancer. Lynch syndrome is a well-known inheritable disease that increases the risk for a variety of cancers, including urothelial carcinomas. Screening of patients with known Lynch syndrome is important to evaluate for development of new primary tumors. Further study may provide more information on what level of follow-up each patient needs. Recent data suggest that mismatch repair mutations confer a greater risk for urothelial cancer. Additional large patient series as well as advancement of molecular testing may provide triage for Lynch syndrome patients in regards to the frequency and type of screening best suited for individual patient.

Entities:  

Keywords:  Lynch syndrome; bladder cancer; genetic susceptibility; microsatellite instability; mismatch repair deficiency; molecular genetics; upper urinary tract cancer

Mesh:

Substances:

Year:  2018        PMID: 29345160     DOI: 10.2217/fon-2017-0346

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  5 in total

1.  MutL homolog 1 germline mutation c.(453+1_454-1)_(545+1_546-1)del identified in lynch syndrome: A case report and review of literature.

Authors:  Xi-Wen Zhang; Zan-Hui Jia; Li-Ping Zhao; Yi-Shi Wu; Man-Hua Cui; Yan Jia; Tian-Min Xu
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

2.  Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.

Authors:  Dora Huang; Surena F Matin; Nathan Lawrentschuk; Morgan Roupret
Journal:  Bladder Cancer       Date:  2018-07-30

Review 3.  Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.

Authors:  Dmitry S Mikhaylenko; Alexander S Tanas; Dmitry V Zaletaev; Marina V Nemtsova
Journal:  J Oncol       Date:  2020-06-17       Impact factor: 4.375

Review 4.  Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.

Authors:  Antonio Lopez-Beltran; Alessia Cimadamore; Ana Blanca; Francesco Massari; Nuno Vau; Marina Scarpelli; Liang Cheng; Rodolfo Montironi
Journal:  Cancers (Basel)       Date:  2021-01-03       Impact factor: 6.639

5.  Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.

Authors:  Jiawei Lu; Yagang Xue; Feng Shen; Hongxing Gu; Haiyong Liu; Jianhua Hou; Huidong Miao
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.